3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Pain, Postoperative
2
Breast Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
1
Oropharyngeal Neoplasms
1
Nevus, Pigmented
1
Neuroma
1
Neuralgia
1
Melanoma
1
Localised Prostate Cancer
1
Chronic Pain
1
Carcinoma, Squamous Cell
1
Interventions
pembrolizumab
60
Cisplatin
43
Cetuximab
25
Carboplatin
24
Paclitaxel
19
Magnetic Resonance Spectroscopy
18
Radiotherapy, Intensity-Modulated
17
Nivolumab
16
Radiotherapy
15
Specimen Handling
14
Docetaxel
13
Platinum
12
1,2-diaminocyclohexaneplatinum II citrate
11
Taxes
8
Fluorouracil
8
Biopsy
7
atezolizumab
6
Radiation
6
(225)Ac-DOTA-c(RGDyK)
6
dostarlimab
5
cemiplimab
5
Ipilimumab
5
Standard of Care
4
Immunoglobulin G
4
Disulfides
4
Cyclophosphamide
4
Bevacizumab
4
Albumin-Bound Paclitaxel
4
130-nm albumin-bound paclitaxel
4
toripalimab
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Squamous Cell Carcinoma of Head and Neck
×
Lidocaine
×
90 days
×
Clear all
NCT06747390
2026-05-12
856397
Abramson Cancer Center at Penn Medicine
Phase 1
Recruiting
30 enrolled